- Home
- NXTS vs PMAX Comparison
NXTS vs PMAX Comparison
Compare NXTS & PMAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | NXTS | PMAX |
|---|---|---|
| Founded | 2009 | 2019 |
| Country | Israel | Hong Kong |
| Employees | N/A | N/A |
| Industry | Agricultural Chemicals | |
| Sector | Industrials | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.4M | 2.7M |
| IPO Year | 2021 | 2024 |
Fundamental Metrics
Financial Performance| Metric | NXTS | PMAX |
|---|---|---|
| Price | $1.56 | $0.91 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 16.2K | ★ 111.7K |
| Earning Date | 05-16-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $263,445.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.55 | $0.20 |
| 52 Week High | $23.80 | $5.20 |
Technical Indicators
Market Signals| Indicator | NXTS | PMAX |
|---|---|---|
| Relative Strength Index (RSI) | 35.76 | 31.25 |
| Support Level | $1.43 | $0.75 |
| Resistance Level | $2.08 | $2.69 |
| Average True Range (ATR) | 0.13 | 0.12 |
| MACD | 0.02 | 0.01 |
| Stochastic Oscillator | 9.00 | 22.22 |
Price Performance
Historical ComparisonAbout NXTS Nexentis Technologies Inc. Common Stock
Nexentis Technologies Inc, is engaged in redefining mitochondrial drug discovery with help of its wholly owned biotechnology subsidiary, MitoCareX Bio focused on drug discovery company dedicated to developing first-in-class therapeutics for inflammatory metabolic diseases and cancer by targeting specific metabolic pathways. The company is also focused on sustainable operations in various industries such as solar projects, and oncology biotechnology.
About PMAX Powell Max Limited
Powell Max Ltd operates as a financial communications platform supporting listed companies and IPO applicants throughout the capital markets lifecycle. Substantially all of the company's revenue is generated from Hong Kong. The group focused on supporting the disclosure, reporting, and transaction needs of corporate clients and their advisors. Its mission is to combine industry knowledge, execution capabilities, and a commitment to service to deliver accurate, timely, and reliable solutions for customers.